Structure | Chemical Name | CAS | MF |
|
N-(phosphonoamidino)sarcosine, dipotassium salt
|
18838-38-5
|
C4H11KN3O5P
|
|
N-(Phosphonomethyl)-Imidodiacetic Acid
|
|
C5H10NO7P
|
|
N-(5'-phosphoribosylformimino)-5-amino-1-(5''-phosphoribosyl)-4-imidazolecarboxamide isomerase
|
|
|
|
N-phosphorylleucyltryptophan
|
56361-75-2
|
C17H24N3O6P
|
|
N-(2-PHOSPHATE-1R-METHYLETHYL)-5Z,8Z,11Z,14Z-EICOSATETRAENAMIDE
|
|
C23H40NO5P
|
|
2-NORPINENE-2-PROPIONALDEHYDE,6,6-DIMETHYL
|
33885-51-7
|
C12H18O
|
|
N-phosphoryl-L-leucinamide
|
83328-05-6
|
|
|
N-phosphopyridoxyl-L-serine
|
76500-10-2
|
|
|
N-(phosphonomethyl) iminodiacetic acid(PMIDA)
|
|
|
|
norpinane
|
|
C7H12
|
|
N-(PHOSPHORUS PENTACHLORIDE)-N,N-DIMETHYL-AMINOMETHYL POLYSTYRENE (16-50 MESH, 1.0-1.5 MMOL/G)
|
|
|
|
N-(5'-phosphopyridoxyl)-glutamate
|
|
C13H18N2O9P-
|
|
N-phosphoryllombricine
|
3160-53-0
|
|
|
N-(phosphonomethyl)glycine trimethylsulfonium salt
|
|
C12H32NO5PS3
|
|
N(1)-(5-phosphoribosyl)-5,6-dimethylbenzimidazole
|
975-91-7
|
C14H19N2O7P
|
|
6-Norpinanecarbonyl chloride, endo- (8CI)
|
6621-26-7
|
C8H11ClO
|
|
N(1)-((5'-phosphoribulosyl)formimino)-5-aminoimidazo-4-carboxamide ribonucleotide
|
36244-86-7
|
C15H25N5O15P2
|
|
N-(5'-phosphoribosyl)anthranilate
|
4220-99-9
|
C12H16NO9P
|
|
N-(Phosphonomethyl)glycine 2-propylamine (1:1)
|
38641-94-0
|
C6H17N2O5P
|
|
N-(Phosphonomethyl)glycine diammonium salt
|
69254-40-6
|
C3H14N3O5P
|
|
N-(Phosphonomethyl)glycine monosodium salt
|
34494-03-6
|
C3H7NO5P.Na
|
|
6-Norpinanecarbonyl chloride (7CI)
|
90003-12-6
|
C8H11ClO
|
|
N-(Phosphonomethyl)glycine monoammonium salt
|
40465-66-5
|
C3H7NO5P.NH4
|
|
6-N-(5'-phosphopyridoxyl)-2-N-acetyl-lysine methyl ester
|
|
|
|
1-Norpinanecarbonyl chloride, 6-oxo- (6CI)
|
98490-87-0
|
C8H9ClO2
|
|
N-(3-Phosphono-2-hydroxypropyl)-N-acetylhydroxyamine
|
|
C5H12NO6P
|
|
N-(3-Phosphono-2-propenyl)-N-formylhydroxylamine
|
|
C4H8NO5P
|
|
N-(Phosphonooxyacetyl)-L-Pro-L-Phe-N-methyl-L-His-[(2S,4S,5S)-5-amino*-4-hydroxy-2-isopropyl-7-methyloctanoyl]-L-Ile-(2-pyridinylmethyl)NH2
|
|
|
|
N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium salt
|
66569-27-5
|
C6H8NNa2O8P
|
|
N-(2-Phosphonoethyl)-2-aminoacetamide
|
|
C4H11N2O4P
|
|
18-Norpimara-8(14),15-dien-4α-ol
|
|
|
|
N-(Phosphonomethyl)-2-aminoacetamide
|
|
C3H9N2O4P
|
|
N-(Phosphonoacetyl)-L-Ala-L-Pro-OH
|
|
|
|
Norpipanone hydrochloride
|
6033-41-6
|
C23H30ClNO
|
|
19-Norpimara-8,15-dien-7β-ol
|
57289-36-8
|
C19H30O
|
|
N-(Phosphonoacetyl)-L-Ala-L-pGlu-OH
|
|
|
|
19-Norpimara-8(14),15-dien-3-one
|
|
|
|
19-Norpimara-8(14),15-dien-4β-ol
|
|
|
|
Norpipanone hydrobromide
|
6033-42-7
|
|
|
N-(2-Phosphonoethyl)-L-phenylalaninamide
|
|
C11H17N2O4P
|
|
N-[4-(Phosphonooxy)butyryl]-L-Pro-L-Phe-N-methyl-L-His-[(2S,4S,5S)-5-amino*-4-hydroxy-2-isopropyl-7-methyloctanoyl]-L-Ile-(2-pyridinylmethyl)NH2
|
|
|
|
N-[4-(Phosphonooxy)butyryl]-L-Pro-L-Phe-N-methyl-L-His-[(2S,4S,5S)-5-amino*-4-hydroxy-2-isopropyl-7-methyloctanoyl]-L-Ile-[(pyridine 1-oxide)-2-ylmethyl]NH2 ester
|
|
|
|
N-(Phosphonomethyl)-N-(isopropyl)-N-(carboxymethyl)aminium
|
|
C6H15NO5P+
|
|
N-(2-Phosphonoethyl)-L-prolinamide
|
|
C7H15N2O4P
|
|
N-[4-[4-[5-(Phosphonooxy)pentyloxy]phenylazo]benzoyl]-L-alanine 1-dodecyl ester
|
|
C33H50N3O8P
|
|
N(O,S)-ethoxycarbonyl heptafluorobutyl ester
|
|
|
|
noroudemansin A
|
|
|
|
Noroxycodone-D3 HCl
|
|
|
|
Noroxycodone HCl
|
52446-25-0
|
C17H20ClNO4
|
|
23-Nor-3-oxo-12-oleanen-28-oic acid
|
|
|
|
16-Nor-15-oxoabieta-8,11,13-trien-18-oic acid
|
200813-31-6
|
C19H24O3
|
|
NOROXYCODONE-D3 HYDROCHLORIDE
|
|
C17H17ClD3NO4
|
|
NOROXYMORPHONE
|
|
C16H17NO4
|
|
NOROXYCODONE (D3, 98%) 100 UG/ML IN METHANOL
|
|
|
|
NOROXYMORPHONE UNLABELED 100 UG/ML IN METHANOL
|
|
|
|
NOROXYMORPHONE HCL CONTROLLED SUBSTANCE CII UB USP(CRM STANDARD)
|
|
|
|
NOROXYCODONEHYDROCHLORIDE,1.0MG/ML(FREEBASE)INMETHANOL
|
|
|
|
NOROXYCODONE-D3,100/MLINMETHANOL
|
|
|
|
NOROXYMORPHONE,100/MLINMETHANOL
|
|
|
|
Noroxycodone-d3
|
|
C17H19NO4
|
|
NOROXOYESSOTOXIN
|
|
|
|
Noroxymorphone -D-Glucuronide
|
76636-08-3
|
C22H25NO10
|
|
NOROXOHOMOYESSOTOXIN
|
|
|
|
NOROXYCODONE HYDROCHLORIDE
|
|
C17H20ClNO4
|
|
NOROXYMORPHONE HYDROCHLORIDE
|
|
C16H18ClNO4
|
|
NOROXYCODONE
|
|
C17H19NO4
|
|
Noroxoagarofuran
|
5986-25-4
|
C14H22O2
|
|
nosF protein, copper processing
|
|
|
|
NPHP1 protein
|
|
|
|
19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-hydroxy-, cyclic 3-(1,2-ethanediyl acetal)
|
42982-49-0
|
C22H30O4
|
|
(3β,5α,17α)-19-Norpregnane-3,17-diol
|
7253-95-4
|
C20H34O2
|
|
(3β,5β,17α)-19-Norpregnane-3,17-diol
|
31658-51-2
|
C20H34O2
|
|
Nor Propoxyphene-d7 Maleate Salt
|
|
C25H31NO6
|
|
Nor Propranolol Hydrochloride
|
62618-09-1
|
C13H16ClNO2
|
|
Nor Propranolol
|
1246819-85-1
|
C13H16ClNO2
|
|
(3α,5α,17α)-19-Norpregnane-3,17-diol
|
6961-15-5
|
C20H34O2
|
|
(3α,5α,17α)-19-Norpregnane-3,17-diol-d4
|
|
C20H34O2
|
|
Norpropanolol HCL
|
|
|
|
19-norpregna-1,3,5(10),20-tetraen-3-O-arabinopyranoside
|
|
|
|
NOR-1 protein
|
|
|
|
NOR-2 protein
|
|
|
|
norpropoxyphene
|
3376-94-1
|
C21H27NO2
|
|
(+/-) NORPROPOXYPHENE MALEATE (D5, 98%) 1.0 MG/ML IN METHANOL
|
|
|
|
19-NOR-1,3,5(10)-PREGNATRIEN-3-OL-20-ONE
|
|
C20H26O2
|
|
Norpregnatrienes
|
|
|
|
19-Norpregn-4-ene-3,20-dione, 9-bromo-11-fluoro-, (11.beta.)-
|
742-90-5
|
|
|
19-NORPROGESTERONE
|
472-54-8
|
C20H28O2
|
|
19-NOR-1,3,5(10), 9(11)-PREGNATETRAEN-3,17-ALPHA, 21-TRIOL-20-ONE 21-ACETATE
|
|
C22H26O5
|
|
Norprene(R) A-60-G laboratory tubing
|
|
|
|
17-epi-Ethynyl estradiol
|
4717-38-8
|
C20H24O2
|
|
19-Norpregn-4-en-20-yn-17-ol, acetate, (17alpha)-
|
36083-55-3
|
|
|
19-Norpregna-4,6-diene-3,11,20-trione
|
|
C20H24O3
|
|
19-Norpregna-1,3,5(10)-triene-20-yne-3,17-diol/13-ethyl-3-hydroxyimino-18,19-dinorpregna-4-ene-20-yne-17α-ol 17-acetate,(1:x)
|
|
|
|
19-Norpregna-4,9-diene-3,20-dione
|
|
C20H26O2
|
|
(+/-)-NORPROPOXYPHENE-D5 MALEATE
|
136765-47-4
|
C25H26D5NO6
|
|
19-Norpregna-1,3,5,7,9-pentaen-21-al, 3,17-bis[(trimethylsilyl)oxy]-, O-methyloxime, (17alpha)-
|
74299-04-0
|
|
|
Norprogesterones
|
|
|
|
19-norpregna-1,3,5(10),20-tetraen-3-O-fucopyranoside
|
|
|
|
Norpregnenes
|
|
|
|
NPH1 protein
|
|
|